22 Tex. Admin. Code § 174.5

Current through Reg. 49, No. 49; December 6, 2024
Section 174.5 - Issuance of Prescriptions
(a) The validity of a prescription issued as a result of a telemedicine medical service is determined by the same standards that would apply to the issuance of the prescription in an in-person setting.
(b) This rule does not limit the professional judgment, discretion or decision-making authority of a licensed practitioner. A licensed practitioner is expected to meet the standard of care and demonstrate professional practice standards and judgment, consistent with all applicable statutes and rules when issuing, dispensing, delivering, or administering a prescription medication as a result of a telemedicine medical service.
(c) A valid prescription must be:
(1) issued for a legitimate medical purpose by a practitioner as part of patient-practitioner relationship as set out in §111.005, of Texas Occupations Code; and
(2) meet all other applicable laws before prescribing, dispensing, delivering or administering a dangerous drug or controlled substance.
(d) Any prescription drug orders issued as the result of a telemedicine medical service, are subject to all regulations, limitations, and prohibitions set out in the federal and Texas Controlled Substances Act, Texas Dangerous Drug Act and any other applicable federal and state law.
(e) Limitation on Treatment of Chronic Pain. Chronic pain is a legitimate medical condition that needs to be treated but must be balanced with concerns over patient safety and the public health crisis involving overdose deaths. The Legislature has already put into place laws regarding the treatment of pain and requirements for registration and inspection of pain management clinics. Therefore, the Board has determined clear legislative intent exists for the limitation of chronic pain treatment through a telemedicine medical service.
(1) Treatment for Chronic Pain. For purposes of this rule, chronic pain has the same definition as used in § 170.2(4) of this title (relating to Definitions). Telemedicine medical services used for the treatment of chronic pain with scheduled drugs by any means other than via audio and video two-way communication is prohibited, unless a patient:
(A) is an established chronic pain patient of the physician or health professional issuing the prescription;
(B) is receiving a prescription that is identical to a prescription issued at the previous visit; and
(C) has been seen by the prescribing physician or health professional defined under Section 111.001(1) of Texas Occupations Code, in the last 90 days either:
(i) in-person; or
(ii) via telemedicine using audio and video two-way communication.
(2) Treatment for Acute Pain. For purposes of this rule, acute pain has the same definition as used in § 170.2(2) of this title. Telemedicine medical services may be used for the treatment of acute pain with scheduled drugs, unless otherwise prohibited under federal and state law.

22 Tex. Admin. Code § 174.5

The provisions of this §174.5 adopted to be effective July 4, 2004, 29 TexReg 6088; amended to be effective October 17, 2010, 35 TexReg 9085; Amended by Texas Register, Volume 40, Number 22, May 29, 2015, TexReg 3148, eff. 6/4/2015; Amended by Texas Register, Volume 42, Number 46, November 17, 2017, TexReg 6515, eff. 11/26/2017; Amended by Texas Register, Volume 45, Number 36, September 4, 2020, TexReg 6174, eff. 7/5/2020 and expired 11/1/2020; Amended by Texas Register, Volume 45, Number 46, November 13, 2020, TexReg 8075, eff. 11/3/2020and expired 1/21/2021; Amended by Texas Register, Volume 46, Number 02, January 8, 2021, TexReg 0235, eff. 1/2/2021 and expired 3/2/2021; Amended by Texas Register, Volume 46, Number 11, March 12, 2021, TexReg 1571, eff. 3/3/2021 and expired 5/1/2021; Amended by Texas Register, Volume 46, Number 20, May 14, 2021, TexReg 3086, eff. 5/2/2021 and expired 6/30/2021; Amended by Texas Register, Volume 46, Number 33, August 13, 2021, TexReg 4919, eff. 7/31/2021and expires 10/13/2021; Amended by Texas Register, Volume 46, Number 40, October 1, 2021, TexReg 6544, eff. 10/7/2021